We are live on ! Find out more
RPCA

Running Point Capital Advisors Portfolio holdings

AUM $367M
1-Year Est. Return 12.19%
This Fund
S&P 500
This Quarter Est. Return
+5.91%
1 Year Est. Return
+12.19%
3 Year Est. Return
+52.1%
5 Year Est. Return
+37.6%
10 Year Est. Return
AUM
$163M
AUM Growth
+$11.9M
Cap. Flow
+$4.59M
Cap. Flow %
2.82%
Top 10 Hldgs %
51.37%
Holding
240
New
15
Increased
48
Reduced
45
Closed
31

Sector Composition

Rank Sector Weight
1 Technology 3.32%
2 Financials 2.41%
3 Healthcare 0.98%
4 Consumer Discretionary 0.66%
5 Consumer Staples 0.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PWZ icon
201
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.14B
$3.26K ﹤0.01%
135
-22,670
-99% -$538K
IMCG icon
202
iShares Morningstar Mid-Cap Growth ETF
IMCG
$3.92B
$2.48K ﹤0.01%
46
CEMI
203
DELISTED
Chembio diagnostics, Inc.
CEMI
$2.2K ﹤0.01%
10,000
JIG icon
204
JPMorgan International Growth ETF
JIG
$471M
$1.73K ﹤0.01%
33
-314
-90% -$16K
SPIP icon
205
State Street SPDR Portfolio TIPS ETF
SPIP
$1.01B
$773 ﹤0.01%
30
-13,586
-100% -$350K
VSS icon
206
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
$308 ﹤0.01%
3
ICVT icon
207
iShares Convertible Bond ETF
ICVT
$7.2B
$278 ﹤0.01%
4
RSP icon
208
Invesco S&P 500 Equal Weight ETF
RSP
$97B
$121 ﹤0.01%
1
EWS icon
209
iShares MSCI Singapore ETF
EWS
$1.04B
$18 ﹤0.01%
1
ADAP
210
DELISTED
Adaptimmune Therapeutics
ADAP
-10,000
Closed -$11K
ADVM
211
DELISTED
Adverum Biotechnologies
ADVM
-1,500
Closed -$14K
AKBA icon
212
Akebia Therapeutics
AKBA
$354M
-10,000
Closed -$3K
AMRN
213
Amarin Corp
AMRN
$299M
-805
Closed -$18K
AMRX icon
214
Amneal Pharmaceuticals
AMRX
$5.85B
-10,000
Closed -$20K
AQST icon
215
Aquestive Therapeutics
AQST
$463M
-10,000
Closed -$12K
ASMB icon
216
Assembly Biosciences
ASMB
$498M
-833
Closed -$16K
AXDX
217
DELISTED
Accelerate Diagnostics
AXDX
-1,000
Closed -$15K
CNDT icon
218
Conduent
CNDT
$244M
-20,000
Closed -$67K
DHC
219
Diversified Healthcare Trust
DHC
$2.15B
-10,000
Closed -$10K
EBND icon
220
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.26B
-8
Closed
HLIT icon
221
Harmonic Inc
HLIT
$1.25B
-10,814
Closed -$141K
IAGG icon
222
iShares Core International Aggregate Bond Fund
IAGG
$10.9B
-545
Closed -$26K
LUMN icon
223
Lumen
LUMN
$6.57B
-10,741
Closed -$78K
PBW icon
224
Invesco WilderHill Clean Energy ETF
PBW
$407M
-10
Closed
PCY icon
225
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
-1,858
Closed -$31K

Similar funds

Running Point Capital Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Running Point Capital Advisors held 240 positions worth $163M, up 7.9% from $151M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Running Point Capital Advisors's Q4 2022 filing shows 15 new, 48 increased, 45 reduced and 31 closed positions. Its largest new stake was First Trust Managed Municipal ETF: 10,692 shares worth $536K. The largest sale was Meta Platforms (Facebook), an estimated $1.48M.

By sector, the portfolio is most concentrated in Technology at 3.3% of assets, down from 3.4% a quarter earlier, followed by Financials and Healthcare.

  • Running Point Capital Advisors's largest Q4 2022 buy was First Trust Managed Municipal ETF: 10,692 shares worth $536K.
  • Running Point Capital Advisors added most to Invesco NASDAQ 100 ETF in Q4 2022, an estimated $1.55M increase.
  • Running Point Capital Advisors's biggest Q4 2022 reduction was Meta Platforms (Facebook), cutting an estimated $1.48M.
  • Running Point Capital Advisors fully exited Tesla in Q4 2022, selling an estimated $234K.
  • Running Point Capital Advisors's ten largest holdings make up 51% of its $163M portfolio in Q4 2022.
  • Running Point Capital Advisors opened 15 new positions and closed 31 in Q4 2022.
  • Running Point Capital Advisors's portfolio value rose 7.9% quarter-over-quarter to $163M.

Based on Running Point Capital Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.